149. 参见印度1970年专利法（1999年修订），第三部分，(d), (e)； 印度2004年《专利（修订）条例》第三段。
150. An Act to Amend the Patent Act and the Food and Drug Act, Bill C-56, 51-52 Elizabeth II (200202003), available at . (Last Visited on Nov. 8, 2005).
151. Patent Act, R.S.C. 1985, ch. P-4.
152. Food & Drugs Act, R.S.C. 1985, c. F-27.
153. 前引150，Patent Act, 21.04(1).
154. 前引150，Patent Act, 21.04(1).
155. 前引150，Patent Act, 21.08.
156. 前引150，Patent Act, 21.17(1).
157. 前引150，Patent Act, 21.17(5).
158. 关于加拿大立法的详细情况，可以参考Mark D. Penner, Prakash Narayanan, Amendments to the Canadian Patent Act to Address Drug Access: Is Help on the Way? 60 Food Drug L.J. 459 (2005).
159. See Consultation—Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Excerpts), at (last visited Aug. 8, 2005).
160. See TRIPS Council Shows Little Progress on Health and Biodiversity, Bridges Wkly Trade News Dig., Nov. 26, 2003, at (Last Visited on Nov. 8, 2005).
161. See France to Apply WTO Generic Drug Pact by 2005 (Nov. 22, 2004), at (last visited Aug. 9, 2005).
162. Proposal for a Regulation of the European Paliment and of the Council on Compulsory Licensing of Patents Relating to the Manufacture of Pharmaceutical Products for Export to Countries with Public Health Problems (Oct. 29, 2004), at